 |
|
Implications of Diabetes in Patients With Acute Coronary Syndromes
The Global Registry of Acute Coronary Events
Kristen Franklin, MD;
Robert J. Goldberg, PhD;
Frederick Spencer, MD;
Werner Klein, MD;
Andrzej Budaj, MD, PhD;
David Brieger, MB, PhD;
Michel Marre, MD;
Philippe Gabriel Steg, MD;
Neelam Gowda, MS;
Joel M. Gore, MD; for the GRACE Investigators
Arch Intern Med. 2004;164:1457-1463.
Background There are limited data describing the presenting characteristics, management, and outcomes of diabetic and nondiabetic patients with an acute coronary syndrome (ACS).
Objective To examine differences in these factors, patients with ST-segment elevation acute myocardial infarction, non–ST-segment elevation acute myocardial infarction, and unstable angina were enrolled in a large multinational coronary disease registry.
Methods The Global Registry of Acute Coronary Events is a prospective observational study of patients hospitalized with an ACS at 94 hospitals in 14 countries. The study sample consisted of 5403 patients with ST-segment elevation acute myocardial infarction, 4725 with non–ST-segment elevation acute myocardial infarction, and 5988 with unstable angina.
Results Approximately 1 in 4 patients presented to participating hospitals with a history of diabetes. Patients with diabetes were older, more often women, with a greater prevalence of comorbidities, and they were less likely to be treated with effective cardiac therapies than nondiabetic patients. Patients with diabetes who developed an ACS were at increased risk for each hospital outcome examined including heart failure, renal failure, cardiogenic shock, and death. These differences remained after adjustment for potentially confounding prognostic factors.
Conclusions A considerable proportion of patients with an ACS has diabetes and is at increased risk for adverse outcomes compared with patients without diabetes. There are certain proven therapeutic strategies that remain underused in the diabetic population. A more widespread awareness of this increased risk and a more diligent use of proven cardiac treatment approaches are indicated for patients with diabetes who develop an ACS.
From the Department of Medicine, Division of Cardiovascular Medicine, University of Massachusetts Medical School, Worcester (Drs Franklin, Goldberg, Spencer, and Gore, and Ms Gowda); Department of Internal Medicine, Division of Cardiology, Karl-Franzens University, Graz, Austria (Dr Klein); Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (Dr Budaj); Coronary Care Unit, Concord Hospital, Sydney, Australia (Dr Brieger); and Departments of Diabetology (Dr Marre) and Cardiology (Dr Steg), Bichat Hospital, Paris, France. The authors have no relevant financial interest in this article.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Diabetes and Mortality Following Acute Coronary Syndromes
Donahoe et al.
JAMA 2007;298:765-775.
ABSTRACT
| FULL TEXT
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2007;28:1598-1660.
FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J Suppl 2007;9:C3-C74.
FULL TEXT
Increasing Cardiovascular Disease Burden Due to Diabetes Mellitus: The Framingham Heart Study
Fox et al.
Circulation 2007;115:1544-1550.
ABSTRACT
| FULL TEXT
Sex-related aspects on abnormal glucose regulation in patients with coronary artery disease
Dotevall et al.
Eur Heart J 2007;28:310-315.
ABSTRACT
| FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J 2007;28:88-136.
FULL TEXT
Review: Heart failure complicating acute myocardial infarction in patients with diabetes: pathophysiology and management strategies
Sulfi and Timmis
British Journal of Diabetes & Vascular Disease 2006;6:191-196.
ABSTRACT
Suspected Acute Coronary Syndrome Patients With Diabetes and Normal Troponin-I Levels Are at Risk for Early and Late Death: Identification of a new high-risk acute coronary syndrome population
Marso et al.
Diabetes Care 2006;29:1931-1932.
FULL TEXT
Factors explaining the under-use of reperfusion therapy among ideal patients with ST-segment elevation myocardial infarction
Alter et al.
Eur Heart J 2006;27:1539-1549.
ABSTRACT
| FULL TEXT
Relation of Characteristics of Metabolic Syndrome to Short-Term Prognosis and Effects of Intensive Statin Therapy After Acute Coronary Syndrome: An analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial
Schwartz et al.
Diabetes Care 2005;28:2508-2513.
ABSTRACT
| FULL TEXT
High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock
Verges et al.
Eur Heart J 2005;26:1734-1741.
ABSTRACT
| FULL TEXT
|
